BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - ashpublications.org
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
[PDF][PDF] BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with …
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - BLOOD, 2006 - researchgate.net
The pathogenetic alteration in chronic myeloid leukemia (CML) is the presence of the BCR-
ABL tyrosine kinase, the product of a reciprocal (9; 22) chromosomal translocation. Targeted …
ABL tyrosine kinase, the product of a reciprocal (9; 22) chromosomal translocation. Targeted …
[HTML][HTML] BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with …
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - Elsevier
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
[PDF][PDF] BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with …
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - BLOOD, 2006 - Citeseer
The pathogenetic alteration in chronic myeloid leukemia (CML) is the presence of the BCR-
ABL tyrosine kinase, the product of a reciprocal (9; 22) chromosomal translocation. Targeted …
ABL tyrosine kinase, the product of a reciprocal (9; 22) chromosomal translocation. Targeted …
[引用][C] BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with …
RD PRESS, Z LOVE, AA TRONNES, RUI YANG… - Blood, 2006 - pascal-francis.inist.fr
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict
the duration of CCR in imatinib mesylate-treated patients with CML CNRS Inist Pascal-Francis …
the duration of CCR in imatinib mesylate-treated patients with CML CNRS Inist Pascal-Francis …
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - ohsu.elsevierpure.com
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Although most patients with chronic myeloid
leukemia (CML) treated with imatinib mesylate achieve a complete cytogenetic response …
leukemia (CML) treated with imatinib mesylate achieve a complete cytogenetic response …
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML.
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - europepmc.org
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - …, 2006 - pubmed.ncbi.nlm.nih.gov
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
[HTML][HTML] BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with …
RD Press, Z Love, AA Tronnes, R Yang, T Tran… - Blood, 2006 - ncbi.nlm.nih.gov
Although most patients with chronic myeloid leukemia (CML) treated with imatinib mesylate
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …
achieve a complete cytogenetic response (CCR), some patients will relapse. To determine …